Advertisement
Life Technologies
Life Technologies

Resisting Cancer

If one out of three people develops cancer, that means two others don’t. Understanding why could lead to insights relevant to prevention and treatment.

Professional Marksman

Charles Sawyers, who began his research career just as the genetic details of human oncogenes were emerging, codeveloped Gleevec, the quintessential targeted cancer therapy.

Bursting Cancer’s Bubble

Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation.

The Challenges of Precision

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

Mining the Outliers

Even when a clinical trial fails, some patients improve. What can researchers learn from these exceptional responders?

News & Opinion

Covering the life sciences inside and out

Scientists who evaluate National Institutes of Health grant applications often identify the projects that will have the biggest scientific impact, according to an analysis.

Researchers develop a method to selectively remove mutated mitochondrial DNA from the murine germline and single-celled mouse embryos.

T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 

Two teams have developed tumor-implantable drug delivery devices to study real-time responses to multiple therapies in cancer patients.

The Nutshell

Daily News Roundup

Researchers probe the neural roots of the ear-ringing condition in a man undergoing brain surgery.

Readers reveal research mishaps

The short interfering RNA-based therapy TKM-Ebola protects monkeys from the viral strain still circulating in West Africa.

One study shows the insects prefer food laced with pesticides, while another adds to the evidence that the chemicals are harmful to some pollinators.

Current Issue

April 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

Personal drug regimens based on xenograft mice harboring a single patient’s tumor still need to prove their true utility in medicine.

If one out of three people develops cancer, that means two others don’t. Understanding why could lead to insights relevant to prevention and treatment.

Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation.

Multimedia

Video, Slideshows, Infographics

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

Cornell researchers probe the brains of jumping spiders to gain insight into the arachnid's visual processing capabilities.

The Marketplace

New Product Press Releases

Features user friendly touchscreen operation which enables a wide range of programmed injection applications.

Personal cytometer for life science research, bioprocessing, water quality and many other applications.

New Balances Support Lean Processes and Bring Comfort to Daily Weighing Tasks

More than 50% lighter than conventional racks, yet don't compromise on strength and are completely recyclable.

Enables More Informed Casework Decisions.

Software provides simple but powerful solution for designing CRISPR experiments.

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist

Featured Comment

Marie-Paule Kieny started off her comment oh so right, but then continued oh so wrong.  In this case, forget the bioethicists. Kieny should have said, "We need to tell the bioethicists that there is no other choice."


- Unknown, Bioethics of Experimental Ebola Treatments
Advertisement